Vaspin in Developing Obesity (Vande-Ob); the Correlation of Waist Circumference and Visceral Fat Percentage with Vaspin Levels in Patients with Type II Diabetes Mellitus
DOI:
https://doi.org/10.3889/oamjms.2019.011Keywords:
vaspin, waist circumference, visceral fat percentage, type II diabetes mellitusAbstract
BACKGROUND: Vaspin concentration was thought to be associated with obesity, impaired insulin sensitivity, and fitness level. The correlation of vaspin and leptin supports the theory of vaspin associated with body fat mass.
AIM: To determine the correlation between visceral fat distributions and serum vaspin level in type II DM patients.
METHODS: We conduct an observational, analytical cross-sectional study. Sixty subjects with type II diabetes mellitus who came to Diabetes Center of Sanglah General Hospital were included consecutively. Each subject has to sign an informed consent before physical and laboratory examination took place. Spearman correlation test was used to analyse the correlation between waist circumference and visceral fat percentage with serum vaspin level since the data were not distributed normally.
RESULTS: Mean laboratory results in all subjects of vaspin levels was 2.389 ± 3.586 ng/ml, mean waist circumference was 94.95 ± 11.78 cm and mean visceral fat percentage was 18.05 ± 23.63%. We found we found no significant correlation between between vaspin with waist circumference (r = -0.044; p = 0.738) and visceral fat percentage (r = -0.103; p = 0.435).
CONCLUSIONS: The vaspin level did not significantly correlate with waist circumference and visceral fat percentage in type II diabetes patients.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Bergmann K, Sypniewska G. Diabetes as a complication of adipose tissue dysfunction. Is there a role for potential new biomarkers? Clin Chem Lab Med 2013; 51(1):177–85. https://doi.org/10.1515/cclm-2012-0490 PMid:23241684 DOI: https://doi.org/10.1515/cclm-2012-0490
Cavan D, Fernande JR, Makarov L, Ogurtsova K, Webber S (editors). IDF diabetes atlas. Seventh ed. Brussels: International Diabetes Federation, 2015.
Dimova R, Tankova T. The role of vaspin in the development of metabolic and glucose tolerance disorders and atherosclerosis. BioMed research international. 2015; 2015. DOI: https://doi.org/10.1155/2015/823481
Hida K, Wada J, Eguchi J, Zhang H, Baba M, et al. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA. 2005; 102:10610–5. https://doi.org/10.1073/pnas.0504703102 PMid:16030142 PMCid:PMC1180799 DOI: https://doi.org/10.1073/pnas.0504703102
Tasnim F, Faruque MO, Zahid H, Ali L. Serum vaspin levels are associated with decreased insulin sensitivity in newly diagnosed type 2 diabetes mellitus in Bangladesh. Journal of Taibah University Medical Sciences. 2015; 10(3):327-32. https://doi.org/10.1016/j.jtumed.2015.02.010 DOI: https://doi.org/10.1016/j.jtumed.2015.02.010
KlotingN, Berndt J, Kralisch S, Kovacs P, Fasshauer M, Schön MR, et al. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun. 2006; 339:430–6. https://doi.org/10.1016/j.bbrc.2005.11.039 PMid:16298335 DOI: https://doi.org/10.1016/j.bbrc.2005.11.039
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 I Made Pande Dwipayana, I Made Siswadi Semadi, Wira Gotera, Made Ratna Saraswati, Ketut Suastika
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0